Shares in the company were up 7% at market open following the first approval for a non-invasive spinal cord stimulator for ...

The spinal cord stimulation technology from Swiss company Onward, called ARC-E-X, helps paralyzed people regain some mobility ...

After a seven-year hiatus from football because of a life-changing injury, Shazier returns to his former team.

The FDA Thursday approved the ARC-EX System designed to restore mobility after spinal cord injury by delivering programmed ...

Life can change in the blink of an eye. For Alix Schneider, this reality struck during a routine day when an unpredict ...

Spinal cord injuries are among the most serious medical conditions, often leading to life-altering physical, emotional, and ...

Antibodies can improve the rehabilitation of people with acute spinal cord injury. Researchers have investigated this with promising results. For the first time, it was possible to identify patient ...

Onward Medical announced today that it received FDA de novo clearance for its ARC-EX spinal cord stimulation (SCS) system.

Researchers have demonstrated the long-term safety and feasibility of neural stem cell transplantation for treating chronic ...

Onward's Arc-Ex spinal cord stimulator earned the FDA's de novo classification and U.S. market authorization, according to a Dec. 19 news release.

A Phase I clinical trial has demonstrated the long-term safety of neural stem cell transplantation for chronic spinal cord ...